FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Group",
  "id": "267225",
  "meta": {
    "versionId": "10",
    "lastUpdated": "2025-12-11T20:35:21.032Z"
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail": {
        "name": "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
      }
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
      "valueMarkdown": "NCT03421379 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267225. Revised 2025-12-11. Available at: https://fevir.net/resources/Group/267225. Computable resource at: https://fevir.net/resources/Group/267225#json."
    }
  ],
  "url": "https://fevir.net/resources/Group/267225",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "267225",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "type": {
        "text": "FEvIR Linking Identifier"
      },
      "system": "https://fevir.net/FLI",
      "value": "NCT03421379 Eligibility Criteria",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "name": "NCT03421379_Eligibility_Criteria",
  "title": "NCT03421379 Eligibility Criteria",
  "status": "active",
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description": "Inclusion Criteria:\n* Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)\n* Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D\n* Hemoglobin A1c (HbA1c) ≤10%\nExclusion Criteria:\n* Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month\n* Have received a total daily dose of insulin \\>1.2 units per kilogram (U/kg)",
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "membership": "conceptual",
  "combinationMethod": "all-of",
  "characteristic": [
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)"
      },
      "exclude": false
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D"
      },
      "exclude": false
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Hemoglobin A1c (HbA1c) ≤10%"
      },
      "exclude": false
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month"
      },
      "exclude": true
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Have received a total daily dose of insulin \\>1.2 units per kilogram (U/kg)"
      },
      "exclude": true
    }
  ]
}